Aortic dissection presenting as acute myocardial infarction: potential harm of antithrombin and antiplatelet therapy

Area of Science:

• Cardiology
• Vascular Surgery

Background:

• Acute myocardial infarction (AMI) management guidelines recommend antithrombin and antiplatelet therapies.
• Nonspecific symptoms of aortic dissection (AD) can lead to misdiagnosis, complicating patient care.
• Differentiating AMI from AD is critical due to distinct treatment pathways.

Purpose of the Study:

• To highlight the importance of considering aortic dissection in patients presenting with acute myocardial infarction symptoms.
• To emphasize the diagnostic challenges posed by the nonspecific presentation of aortic dissection.
• To underscore the definitive role of surgical intervention in managing diagnosed aortic dissection.

Main Methods:

• Review of current clinical guidelines for acute myocardial infarction treatment.
• Analysis of diagnostic considerations for patients presenting with symptoms suggestive of myocardial infarction.
• Evaluation of treatment strategies for aortic dissection.

Main Results:

• Aortic dissection requires high clinical suspicion due to its nonspecific symptoms, often mimicking other conditions like myocardial infarction.
• Surgical intervention remains the definitive treatment for aortic dissection, irrespective of concurrent antithrombin and antiplatelet therapy used for myocardial infarction.

Conclusions:

• Clinicians must maintain a high index of suspicion for aortic dissection in patients with acute myocardial infarction symptoms.
• Prompt diagnosis and surgical intervention are crucial for effective management of aortic dissection.
• Antithrombin and antiplatelet therapies, while standard for myocardial infarction, do not replace the need for surgical repair in aortic dissection.